Geneva, Oct. 9 -- International Clinical Trials Registry received information related to the study (NCT07855640) titled 'Anti-PD-1 in Combination With Systemic Chemotherapy With Nab-paclitaxel Intraperitoneal Infusion for Untreated Advanced Gastric Cancer With Malignant Ascites' on Sept. 28.
Study Type: Observational
Primary Sponsor: Zhejiang Cancer Hospital
Condition:
Gastric Cancer Peritoneal Metastases
Gastric Cancer (GC)
Ascites, Malignant
Recruitment Status: Recruiting
Date of First Enrollment: July 1, 2026
Target Sample Size: 50
Countries of Recruitment:
China
To know more, visit https://clinicaltrials.gov/study/NCT07855640
Published by HT Digital Content Services with permission from Health Daily Digest....